Therapist Explains What Psychedelics Do, What Talk Therapy Can’t

Interest in the use of psychedelics in therapy has increased over the last couple of years, with researchers finding that drugs such as psilocybin, LSD and ketamine may be useful in the treatment of different mental-health conditions.

According to one therapist, psychedelics are drugs that enable the dissolution of the individual ego. This is the objective of many spiritual traditions, where one realizes that they aren’t an individual island living a separate life but a smaller cog in a huge machine.

By the aforementioned definition, psychedelics include ayahuasca, DMT, ketamine, psilocybin and LSD. It is important to note MDMA is not a part of this definition.

So, how are these substances linked to psychotherapy, and why do they matter?

To let go of one’s ego isn’t an easy experience, particularly if one is holding on to their sense of self or other issues. Psychedelics help with this in a way, but for it to be fully effective, one has to learn how to fully let go and experience everything in their reality. Talk therapy helps in such instances, mainly because it works for many individuals in different situations.

However, there are instances where talk therapy may not work. This includes when an individual experienced hurt in their early childhood. In such instances where a person was wounded even before they could talk, that trauma is very deep.

For example, individuals who have primal wounds of feeling unwanted feel the wounds at a deep level. While speaking to someone like this in a rational way about how their mother putting them up for adoption had nothing to do with them or how they are loved by the parents who adopted them sounds like a good idea, it will not make a difference as the words do nothing to help with primal wounds.

This is where psychedelics come in, because they venture deeper than words can. The substances open an individual up to a deeper and broader experience of themselves, allowing them to connect to their inner selves. Psychedelics work in a manner different to talk therapy and may bring about profound healing in a person, in a way faster than decades of talk therapy could.

It should be noted that this doesn’t always happen, and sometimes, having a psychedelic experience once isn’t enough to heal an individual’s wounds. However, psychedelics offer an alternative route to healing that may be very effective in a way that other conventional treatments aren’t. It is this alternative path to healing that startups such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) are looking to leverage through the drug-development programs that they are running.

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com

PsychedelicNewsWire is powered by IBN